Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Clin Nephrol ; 78(4): 328-31, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22981036

RESUMO

Infection with Streptococcus pyogenes, a Group A beta-hemolytic streptococcus (GAS), is a rare cause of hemolyticuremic syndrome (HUS). Invasive infections with Streptococcus pneumoniae that produce neuraminidase are a well-recognized cause of HUS without diarrhea. The Thomsen- Friedenreich antigen (T antigen) plays a role in the pathophysiology of pneumococcal HUS. We describe the case of a 3-year-old boy with GAS-associated HUS and show how T-antigen exposure was implicated in this case. He had no diarrhea and cultures for blood, urine, and stool were negative. The urinary pneumococcal antigen was negative; his direct Coombs test was positive. Glomerular capillary loops, tubular epithelium on his renal biopsy specimen, and red blood cells in his blood smear showed positive fluorescence with anti-T lectin. Although the pathogenesis of GAS-associated HUS is not well understood, T-antigen exposure may be implicated in some cases with GAS-associated HUS.


Assuntos
Antígenos Glicosídicos Associados a Tumores/imunologia , Síndrome Hemolítico-Urêmica/etiologia , Infecções Estreptocócicas/complicações , Streptococcus pyogenes , Pré-Escolar , Complemento C3/análise , Humanos , Masculino
3.
Drug Metab Pharmacokinet ; 26(3): 280-7, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21383523

RESUMO

We evaluated the pharmacokinetics of routinely administered bosentan in 46 Japanese pediatric patients with pulmonary arterial hypertension. Plasma samples were taken twice at times corresponding to the peak and trough concentrations following repetitive oral administration. The population pharmacokinetic parameters of bosentan were estimated by use of the NONMEM program, in which a one-compartment model with repetitive bolus dosing was parameterized in terms of the oral clearance (CL/F) and elimination rate constant (k). Polymorphisms of CYP3A5, SLCO1B1, SLCO1B3, and SLCO2B1 had no significant effect on the disposition of bosentan. In addition, the pharmacokinetics of bosentan was not altered by heart failure or coadministration of sildenafil. In contrast, weight (WT)-normalized values of CL/F were correlated negatively with age (AGE). The final population mean values of CL/F and k were estimated to be 0.409 · (1 - 0.0377 · (AGE - 3.81)) · WT L/h and 0.175 h(-1), respectively.


Assuntos
Povo Asiático/genética , Hipertensão Pulmonar/tratamento farmacológico , Sulfonamidas/farmacocinética , Adolescente , Fatores Etários , Hidrocarboneto de Aril Hidroxilases/genética , Teorema de Bayes , Peso Corporal , Bosentana , Criança , Pré-Escolar , Simulação por Computador , Citocromo P-450 CYP2C9 , Citocromo P-450 CYP3A/genética , Interações Medicamentosas , Hipertensão Pulmonar Primária Familiar , Feminino , Genótipo , Insuficiência Cardíaca/sangue , Insuficiência Cardíaca/complicações , Humanos , Hipertensão Pulmonar/complicações , Lactente , Recém-Nascido , Transportador 1 de Ânion Orgânico Específico do Fígado , Masculino , Modelos Biológicos , Transportadores de Ânions Orgânicos/genética , Transportadores de Ânions Orgânicos Sódio-Independentes/genética , Piperazinas/farmacologia , Piperazinas/uso terapêutico , Polimorfismo de Nucleotídeo Único/fisiologia , Purinas/farmacologia , Purinas/uso terapêutico , Citrato de Sildenafila , Membro 1B3 da Família de Transportadores de Ânion Orgânico Carreador de Soluto , Sulfonamidas/administração & dosagem , Sulfonamidas/sangue , Sulfonamidas/uso terapêutico , Sulfonas/farmacologia , Sulfonas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA